Results 1 to 10 of about 6,785 (118)

Development and validation of deprescribing algorithms for kidney failure using consensus development methodology [PDF]

Journal of Pharmaceutical Policy and Practice
Background Patients with kidney failure (KF) are at high risk of inappropriate polypharmacy; however, this can be mitigated through deprescribing.
Amani Zidan, Kheloud Awad, Safeya Habib, Noor Alsalemi, Hager Elgeed, Abdullah Hamad, Hassan Al-Malki, Mohamad Alkadi, Mohamed Elesnawi, Fatima Babiker, Rania Ibrahim, Muhammad Abdul Hadi, Ahmed Awaisu   +12 more
doaj   +2 more sources

Barriers to and facilitators of deprescribing for older people in secondary care in Saudi Arabia: a qualitative study using a theory-based approach [PDF]

BMC Geriatrics
Background In Saudi Arabia, over 55% of older people are exposed to potentially inappropriate medications. Deprescribing, a structured process to identify and discontinue unnecessary or harmful medications under medical supervision, by healthcare ...
Turkeah M. Alenzy, Heather E. Barry, Saad A. Alkahtani, Carole Parsons   +3 more
doaj   +2 more sources

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing

Exploratory Research in Clinical and Social Pharmacy, 2022
The first Danish symposium on evidence-based deprescribing was held in September 2019. The symposium aimed to increase the awareness of deprescribing in general, to discuss the importance of deprescribing, and, thus, a potential consensus on key issues ...
Lykke I. Kaas Oldenburg, Dagmar Dalin, Anne Mette Drastrup, Charlotte Vermehren   +3 more
doaj   +1 more source

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process

BMC Primary Care, 2023
Background  Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of medication use review that helps to reduce polypharmacy, inappropriate medication uses and medication ...
Wuraola Akande-Sholabi, Comfort O. Ajilore, Temitope Ilori   +2 more
doaj   +1 more source

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review

BMJ Open, 2022
Objective To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).Design/setting We conducted a systematic review ...
Nicolas Rodondi, Carole Elodie Aubert, Laureline Brunner   +2 more
doaj   +1 more source

Perspectives on Deprescribing in long-term care: qualitative findings from nurses, aides, residents, and proxies

BMC Nursing, 2023
Background Deprescribing initiatives in the long-term care (LTC) setting are often unsuccessful or not sustained. Prior research has considered how physicians and pharmacists feel about deprescribing, yet little is known about the perspectives of ...
Milta O. Little, Emily J. Hecker, Cathleen S. Colon-Emeric, Laurie Herndon, Eleanor S. McConnell, Tingzhong Michelle Xue, Sarah D. Berry   +6 more
doaj   +1 more source

General practitioner attitudes and confidence to deprescribing for elderly patients

Geriatric Care, 2020
Deprescribing is a patient-centered process of medication withdrawal intended to achieve improved health outcomes through discontinuation of one or more medications that are either potentially harmful or no longer required.
Pier Riccardo Rossi, Sarah E. Hegarty, Vittorio Maio, Marco Lombardi, Andrea Pizzini, Aldo Mozzone, Marzio Uberti, Simonetta Miozzo   +7 more
doaj   +1 more source

Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study

Gerontology and Geriatric Medicine, 2021
Introduction Polypharmacy is common in the frail nursing home population and associated with an increased risk of adverse events, unplanned hospitalizations, and increased all-cause mortality.
Anne G. R. Visser MD, Jos M. G. A. Schols MD,, Mathieu A. L. M. Prevoo MD, Rob Janknegt PhD, Bjorn Winkens PhD   +4 more
doaj   +1 more source

Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups

Clinics and Practice, 2023
In the last two decades in the United States (US), the previous research has focused on medication optimization, including polypharmacy. Polypharmacy is associated with several negative outcomes, which may be resolved by deprescribing medications that ...
Devin Scott, Alina Cernasev, Rachel E. Barenie, Sydney P. Springer, David R. Axon   +4 more
doaj   +1 more source

Weighing the necessities and concerns of deprescribing among older ambulatory patients and primary care trainees: a qualitative study

BMC Primary Care, 2023
Background Deprescribing can be a challenging and complex process, particularly for early career doctors such as primary care trainees. To date, there is limited data from patients’ and doctors’ perspectives regarding the deprescribing of medications in ...
Sheron Sir Loon Goh, Pauline Siew Mei Lai, Siti Nurkamilla Ramdzan, Kit Mun Tan   +3 more
doaj   +1 more source